Mounjaro, a relatively novel here drug approved by the FDA in May 2023, is generating significant attention within the medical community for its potential to treat Type 2 diabetes. While not a cure, Mounjaro appears to be delivering substantial results in managing blood sugar levels and lowering the need for other medications. Early studies show pr